Helen Susan Kim - 26 Aug 2021 Form 4 Insider Report for Applied Molecular Transport Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Aug 2021, 20:45:35 UTC
Prior SEC filing
25 Aug 2021
Next SEC filing
02 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brandon Hants Attorney-in-Fact for Helen Kim

Key filing fact

Helen Susan Kim filed Form 4 for Applied Molecular Transport Inc. on 27 Aug 2021.

Key facts

  • This page summarizes Helen Susan Kim's Form 4 filing for Applied Molecular Transport Inc..
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Aug 2021, 20:45.

Change

  • Previous filing in this sequence was filed on 25 Aug 2021.
  • Current net transaction value: -$453,499.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMTI transaction

Common Stock

Sale

Transaction value
$406,771
Shares
-13,505
Change %
-2.3%
Price
$30.12*
Shares after
576,509
Date
26 Aug 2021
Ownership
Direct
Footnotes
F1, F2
AMTI transaction

Common Stock

Sale

Transaction value
$17,304
Shares
-558
Change %
-0.1%
Price
$31.01*
Shares after
575,951
Date
26 Aug 2021
Ownership
Direct
Footnotes
F1, F3
AMTI transaction

Common Stock

Sale

Transaction value
$21,564
Shares
-701
Change %
-0.12%
Price
$30.76*
Shares after
575,250
Date
27 Aug 2021
Ownership
Direct
Footnotes
F1, F4
AMTI transaction

Common Stock

Sale

Transaction value
$7,860
Shares
-250
Change %
-0.04%
Price
$31.44*
Shares after
575,000
Date
27 Aug 2021
Ownership
Direct
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on July 7, 2021.

Footnote F2

The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.915, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.045, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.25 to $31.24, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.25 to $31.98, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .